PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer

PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer

Show other versions (1)

<h4>Background</h4> Immune checkpoint inhibition is effective in several cancers. Expression of programmed death-ligand 1 (PD-L1) on circulating tumor or immune effector cells could provide insights into selection of patients for immune checkpoint inhibition. <h4>Methods</h4>...

Full description

Bibliographic Details
Main Authors: Elizabeth P. Darga, Emily M. Dolce, Fang Fang, Kelley M. Kidwell, Christina L. Gersch, Steven Kregel, Dafydd G. Thomas, Anoop Gill, Martha E. Brown, Steven Gross, Mark Connelly, Michael Holinstat, Erin F. Cobain, James M. Rae, Daniel F. Hayes, Costanza Paoletti
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592410/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592410/?tool=EBI

Similar Items